Could a common heart drug help fix damaged hearts from birth?
NCT ID NCT06693674
Summary
This study is testing whether a medication called sacubitril-valsartan, often used for heart failure, can improve the heart's structure and function in adults who were born with heart defects. Researchers will compare the drug to a placebo in 45 participants, measuring changes in heart scans, blood tests, and quality-of-life surveys. The goal is to see if this treatment can help control the long-term effects of congenital heart disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.